Ryousuke Irie

This inventor holds 3 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Medivation Prostate Therapeutics, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryousuke Irie. Retrieved from https://idiyas.com/inventor/ryousuke-irie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 8)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

Medivation Prostate Therapeutics, Inc.

patents

where one patent can have more than one assignee

Years Active: 2023-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502357 - Formulations of enzalutamide (2025-12-23),

2. 12447128 - Formulations of enzalutamide (2025-10-21),

3. 11839689 - Formulations of enzalutamide (2023-12-12),

Title: The Innovative Contributions of Ryousuke Irie

Introduction

Ryousuke Irie is a notable inventor based in Japan, recognized for his work in the pharmaceutical field. He has made significant contributions to the development of formulations aimed at treating hyperproliferative disorders. His expertise in this area has led to innovative approaches in drug formulation.

Latest Patents

Although Ryousuke Irie currently holds no patents, his work on the formulation of enzalutamide is noteworthy. This formulation involves a solid dispersion containing amorphous enzalutamide and hydroxypropyl methylcellulose acetate succinate. The application of this formulation is particularly relevant in the treatment of hyperproliferative disorders.

Career Highlights

Throughout his career, Ryousuke Irie has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Medivation Prostate Therapeutics, Inc. His experience in these organizations has contributed to his understanding of drug development and formulation.

Collaborations

Ryousuke Irie's collaborations with leading pharmaceutical companies have allowed him to leverage resources and expertise in the field. His work with Astellas Pharma and Medivation Prostate Therapeutics has facilitated advancements in drug formulations, particularly in oncology.

Conclusion

Ryousuke Irie is a dedicated inventor whose contributions to pharmaceutical formulations are significant. His

Profile summary based on public USPTO records.